CN105343358A - Traditional Chinese medicine capsules for treating coronary heart disease - Google Patents
Traditional Chinese medicine capsules for treating coronary heart disease Download PDFInfo
- Publication number
- CN105343358A CN105343358A CN201510950131.0A CN201510950131A CN105343358A CN 105343358 A CN105343358 A CN 105343358A CN 201510950131 A CN201510950131 A CN 201510950131A CN 105343358 A CN105343358 A CN 105343358A
- Authority
- CN
- China
- Prior art keywords
- grams
- heart disease
- coronary heart
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 26
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 25
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 8
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 8
- 235000009392 Vitis Nutrition 0.000 claims description 13
- 241000219095 Vitis Species 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 13
- 230000003203 everyday effect Effects 0.000 claims description 9
- 241000756943 Codonopsis Species 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 7
- 241000218628 Ginkgo Species 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 7
- 241000180649 Panax notoginseng Species 0.000 claims description 7
- 230000024241 parasitism Effects 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 230000007774 longterm Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 8
- 208000031229 Cardiomyopathies Diseases 0.000 abstract description 2
- 208000004124 rheumatic heart disease Diseases 0.000 abstract description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 abstract 2
- 235000012333 Vitis X labruscana Nutrition 0.000 abstract 2
- 240000006365 Vitis vinifera Species 0.000 abstract 2
- 235000014787 Vitis vinifera Nutrition 0.000 abstract 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000632227 Antenoron Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000729196 Lycopus lucidus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000316342 Taxillus Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 208000004224 Opium Dependence Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000009561 tongxinluo Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to traditional Chinese medicine capsules for treating a coronary heart disease. The traditional Chinese medicine capsules comprise traditional Chinese medicines by mass as follows: 5 g of ginkgo leaves, 5 g of pseudo ginseng, 5 g of pilose asiabell roots, 4 g of szechuan lovage rhizome, 4 g of Chinese angelica, 3 g of longhairy antenoron herb, 2 g of hiraute shiny bugleweed herb, 2 g of Chinese taxillus twigs, 2 g of grape seeds, 2 g of astragalus membranaceus and 2 g of safflower, wherein the grape seeds are fermented. According to the traditional Chinese medicine capsules, the traditional Chinese medicines are matched, have a good treatment effect on the coronary heart disease and take effect well when used clinically. 38 cases of patients in four years show that the traditional Chinese medicine capsules can effectively treat the coronary heart disease, the effective rate reaches 92.11%, and the capsules also have a good curative effect on rheumatic heart diseases and cardiomyopathy.
Description
Technical field
The present invention relates to a kind of Chinese medicinal capsule for the treatment of coronary heart disease, belong to Chinese medicine formula technical field.
Background technology
Coronary atherosclerotic heart disease is coronary artery generation atherosclerotic lesion and causes lumen of vessels stenosis or occlusion, causes myocardial ischemia, anoxia or downright bad and heart disease that is that cause, is usually called as " coronary heart disease ".But the scope of coronary heart disease may be more extensive, also comprises inflammation, thromboembolism etc. and cause luminal stenosis or obturation.Coronary heart disease is divided into 5 large classes by World Health Organization (WHO): silent ischemia (latent coronary heart disease), angina pectoris, myocardial infarction, ischemic heart failure (ischemic heart desease) and sudden death 5 kinds of Clinical types.Stable coronary heart disease and acute coronary syndrome is usually divided in clinical.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicinal capsule for the treatment of coronary heart disease, to treat for patients with coronary heart disease better, improve therapeutic effect.
To achieve these goals, technical scheme of the present invention is as follows.
A kind of Chinese medicinal capsule for the treatment of coronary heart disease, be made up of following Chinese medicine: Folium Ginkgo, Radix Notoginseng, Radix Codonopsis, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Herba Lysimachiae, Herba Lycopi, parasitism, Semen Vitis viniferae, Radix Astragali Flos Carthami, the quality of upper each component is: Folium Ginkgo 5 grams, Radix Notoginseng 5 grams, Radix Codonopsis 5 grams, Rhizoma Chuanxiong 4 grams, Radix Angelicae Sinensis 4 grams, Herba Lysimachiae 3 grams, Herba Lycopi 2 grams, parasitism 2 grams, Semen Vitis viniferae 2 grams, the Radix Astragali 2 grams, 2 grams, Flos Carthami, wherein, Semen Vitis viniferae is the Semen Vitis viniferae after fermentation.
Above-mentioned Chinese medicinal capsule preparation method is: smashed the Chinese medicine of above-mentioned each component to pieces powdered, be prepared into capsule after giving mix homogeneously, every 0.5g or 0.4g.
The concrete instructions of taking of above-mentioned Chinese medicinal capsule is, when the heart state of an illness is not serious, each 5 ~ 6, every day 3 times, takes about 5 days; Move back time every day 3 times, each 4, take about 5 days; Move back time every day 3 times again, each 3.Now enter the program of nourishing heart, if felt heart after 12 days, all have been normal, withdrawal; Because entering the program of nourishing heart, long-term taking.
When above-mentioned Chinese medicinal capsule uses, should be noted that following item:
1) after this medicine takes about two days, chest has pain, is not heart (can try with deep breathing pole) in fact, but chest soft tissue, blood stasis starts from breaking body here and goes out, and this symptom is slept and just substantially disappeared an evening.
2) heart pulse in about 3 days is dynamic obviously strong, and sensation uncomfortable in chest disappears completely, the complete proper flow of promoting the circulation of blood of heart.
3) after, gradually can carry out certain outdoor activities, but sexual life less as well, large motion and ass work wouldn't be applicable to.
4) the smoked deep fried foodstuff of ban on opium-smoking and the opium trade.
5) patient that heart did operation (support, bridging) can use this medicine under the management of doctor.
The herbal function of above-mentioned each tcm components is as follows:
Folium Ginkgo: control chest pain, heart beating is overrun, and reduces blood concentration, vessel softening.
Radix Notoginseng: blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain, antithrombotic, heart ischemia, tissue regeneration promoting of enriching blood.
Radix Codonopsis: blood fat reducing, the blood that disappears blocks up, QI invigorating, spleen invigorating.
Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping, changes knot dissipating depression of QI.
Radix Angelicae Sinensis: anti-hypoxia, immunity moderation function, enriches blood and invigorates blood circulation, vessel softening.
Herba Lysimachiae: anti-cardiac-cerebral ischemia, soft blood vessel, diuresis.
Herba Lycopi: invigorate blood circulation, controls blood stasis, antiinflammatory diuresis.
Parasitic: nutrient blood side is empty, invigorating the liver and kidney of nourishing blood.
Semen Vitis viniferae: soft heart cerebrovascular, reduces blood fat, anti-sclerosis.
The Radix Astragali: vessel softening, primordial QI reinforcing reinforcing, adds excitometabolic and gastrointestinal function.
Flos Carthami: invigorating blood circulation can be through, blood stasis removing pain relieving, antithrombotic.
This beneficial effect of the invention is: the Chinese medicinal capsule in the present invention has following effect: antiinflammatory disappears bitterly, and clear thrombosis.Make blood vessel, blood flow obtains proper flow.The operation of complete each function of heart, reinforces cardiovascular greatly, the defensive ability/resistance ability of cardiac muscle.Often take, pathological changes factor can be disappeared in bud in advance, the risk of next time showing effect can be postponed greatly, even no longer occur.All medicines coordinates, and has better therapeutic effect to coronary heart disease, clinical use often receive good effect.In 4 years, by showing the use of 38 patients, this medicine effectively can treat coronary heart disease, and effective percentage reaches 92.11%.This capsule also has good curative effect to rheumatic heart disease and cardiomyopathy.
Detailed description of the invention
Below in conjunction with embodiment, the specific embodiment of the present invention is described, better to understand the present invention.
Embodiment
The Chinese medicinal capsule of the treatment coronary heart disease in the present embodiment, be made up of following Chinese medicine: Folium Ginkgo, Radix Notoginseng, Radix Codonopsis, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Herba Lysimachiae, Herba Lycopi, parasitism, Semen Vitis viniferae, Radix Astragali Flos Carthami, the quality of upper each component is: Folium Ginkgo 5 grams, Radix Notoginseng 5 grams, Radix Codonopsis 5 grams, Rhizoma Chuanxiong 4 grams, Radix Angelicae Sinensis 4 grams, Herba Lysimachiae 3 grams, Herba Lycopi 2 grams, parasitism 2 grams, Semen Vitis viniferae 2 grams, the Radix Astragali 2 grams, 2 grams, Flos Carthami, wherein, Semen Vitis viniferae is the Semen Vitis viniferae after fermentation.
Above-mentioned Chinese medicinal capsule preparation method is: smashed the Chinese medicine of above-mentioned each component to pieces powdered, be prepared into capsule after giving mix homogeneously, every 0.5g or 0.4g.
The concrete instructions of taking of above-mentioned Chinese medicinal capsule is, when the heart state of an illness is not serious, each 5 ~ 6, every day 3 times, takes about 5 days; Move back time every day 3 times, each 4, take about 5 days; Move back time every day 3 times again, each 3.Now enter the program of nourishing heart, if felt heart after 12 days, all have been normal, withdrawal; Because entering the program of nourishing heart, also can long-term taking.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data: inventor have collected 76 routine patients with coronary heart disease between in October ,-2015 in October, 2012 altogether, wherein, 20 years old ~ 50 years old age, 1 month ~ half a year of the state of an illness.Be divided at random: treatment group 38 example, matched group 38 example.The data there was no significant differences such as two groups of ages, have comparability.
2, test method: (1) matched group takes certain city's TONGXINLUO JIAONANG, takes to specifications.21 days courses for the treatment of.(2) the oral capsule of the present invention for the treatment of group, early, middle and late each once.21 days courses for the treatment of.(3) criterion of therapeutical effect and therapeutic outcome: criterion of therapeutical effect: recovery from illness: the clinical symptoms of coronary heart disease all disappears.Take a turn for the better: the clinical symptom relief of coronary heart disease, the state of an illness is controlled.Invalid: the clinical symptoms of coronary heart disease is without being clearly better or increasing the weight of.With recovery from illness and the calculating effective percentage that takes a turn for the better.Treatment statistical result is in table 1.
Table 1 liang group comparitive study
As can be seen here, the medicine adopting prescription of the present invention obtained can safe and effective treatment coronary heart disease.
Toxicity test:
Test drug is the powder in the embodiment of the present invention 2.Experimental animal is ICR kind white mice, body weight 18 ~ 22 grams, male and female half and half, totally 40.Test method is, fasting, after 12 hours, gives mice lavage 4 months by 20 grams/kilogram, and long term toxicity test result shows, white mice body weight, Liver and kidney function, hemogram etc. and matched group no significant difference, shows that the safety of this medicine is large, belongs to nontoxic rank.
The above is the preferred embodiment of the present invention; it should be pointed out that for those skilled in the art, under the premise without departing from the principles of the invention; can also make some improvements and modifications, these improvements and modifications are also considered as protection scope of the present invention.
Claims (3)
1. treat the Chinese medicinal capsule of coronary heart disease for one kind, it is characterized in that: be made up of following Chinese medicine: Folium Ginkgo, Radix Notoginseng, Radix Codonopsis, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Herba Lysimachiae, Herba Lycopi, parasitism, Semen Vitis viniferae, Radix Astragali Flos Carthami, the quality of upper each component is: Folium Ginkgo 5 grams, Radix Notoginseng 5 grams, Radix Codonopsis 5 grams, Rhizoma Chuanxiong 4 grams, Radix Angelicae Sinensis 4 grams, Herba Lysimachiae 3 grams, Herba Lycopi 2 grams, parasitism 2 grams, Semen Vitis viniferae 2 grams, the Radix Astragali 2 grams, 2 grams, Flos Carthami, wherein, Semen Vitis viniferae is the Semen Vitis viniferae after fermentation.
2. the Chinese medicinal capsule for the treatment of coronary heart disease according to claim 1, is characterized in that: described Chinese medicinal capsule preparation method is: smashed the Chinese medicine of above-mentioned each component to pieces powdered, be prepared into capsule after giving mix homogeneously, every 0.5g or 0.4g.
3. the Chinese medicinal capsule for the treatment of coronary heart disease according to claim 1, is characterized in that: the concrete instructions of taking of described Chinese medicinal capsule is, when the heart state of an illness is not serious, each 5 ~ 6, every day 3 times, takes 5 days; Move back time every day 3 times, each 4, take 5 days; Move back time every day 3 times again, each 3; Now enter the program of nourishing heart, if felt heart after 12 days, all have been normal, withdrawal; Because entering the program of nourishing heart, also can long-term taking.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510950131.0A CN105343358A (en) | 2015-12-18 | 2015-12-18 | Traditional Chinese medicine capsules for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510950131.0A CN105343358A (en) | 2015-12-18 | 2015-12-18 | Traditional Chinese medicine capsules for treating coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105343358A true CN105343358A (en) | 2016-02-24 |
Family
ID=55319516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510950131.0A Pending CN105343358A (en) | 2015-12-18 | 2015-12-18 | Traditional Chinese medicine capsules for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105343358A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113209283A (en) * | 2021-06-03 | 2021-08-06 | 绵阳德康疼痛医院 | Nerve rehabilitation powder and preparation and use methods thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1030183A (en) * | 1987-06-30 | 1989-01-11 | 马德林 | A kind of manufacture method of preventing and treating the coronary heart disease medicine for external use |
| CN1726975A (en) * | 2005-07-28 | 2006-02-01 | 乔国强 | Chinese traditional medicine for treating coronar yheart disease an high blood pressure |
| CN101172141A (en) * | 2005-05-24 | 2008-05-07 | 马希文 | Drug for curing coronary disease |
| CN101721638A (en) * | 2009-11-27 | 2010-06-09 | 湖北民康制药有限公司 | Oral liquor for treating coronary heart disease |
| CN102526673A (en) * | 2012-02-06 | 2012-07-04 | 王健 | Chinese medicine capsule, Chinese medicine liquid and health-care oral liquid for treating dilated cardiomyopathy and manufacture method |
| CN104189668A (en) * | 2014-08-01 | 2014-12-10 | 济南环太机电技术有限公司 | Traditional Chinese medicine composition for treating coronary heart disease |
-
2015
- 2015-12-18 CN CN201510950131.0A patent/CN105343358A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1030183A (en) * | 1987-06-30 | 1989-01-11 | 马德林 | A kind of manufacture method of preventing and treating the coronary heart disease medicine for external use |
| CN101172141A (en) * | 2005-05-24 | 2008-05-07 | 马希文 | Drug for curing coronary disease |
| CN1726975A (en) * | 2005-07-28 | 2006-02-01 | 乔国强 | Chinese traditional medicine for treating coronar yheart disease an high blood pressure |
| CN101721638A (en) * | 2009-11-27 | 2010-06-09 | 湖北民康制药有限公司 | Oral liquor for treating coronary heart disease |
| CN102526673A (en) * | 2012-02-06 | 2012-07-04 | 王健 | Chinese medicine capsule, Chinese medicine liquid and health-care oral liquid for treating dilated cardiomyopathy and manufacture method |
| CN104189668A (en) * | 2014-08-01 | 2014-12-10 | 济南环太机电技术有限公司 | Traditional Chinese medicine composition for treating coronary heart disease |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113209283A (en) * | 2021-06-03 | 2021-08-06 | 绵阳德康疼痛医院 | Nerve rehabilitation powder and preparation and use methods thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579774B (en) | Traditional Chinese medicine composition for treating tuberculosis of cervical lymph nodes | |
| CN1240416C (en) | Medicine for curing hypertension and its preparation method | |
| CN101062377B (en) | Adhesive plaster for diminishing inflammation, expelling wind and cold | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN102512632A (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN102210835B (en) | Traditional Chinese medicine for treating coronary disease | |
| CN104173458B (en) | A kind of have Chinese medicine composition preventing and treating hyperuricemia effect and preparation method thereof | |
| CN103520366A (en) | Traditional Chinese medicine for treating spastic hemiplegia after stroke | |
| CN102343049B (en) | Chinese medicinal capsules for treating hypertension due to liver-yang hyperactivity | |
| CN105343358A (en) | Traditional Chinese medicine capsules for treating coronary heart disease | |
| CN103610936A (en) | Chinese medicinal preparation for treating coronary heart disease and preparation method thereof | |
| CN102631607B (en) | Medicament for treating cardiovascular diseases and preparation method thereof | |
| CN102309561B (en) | Pharmaceutical composition used for preventing and treating urarthritis and hyperuricemia | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN104800772A (en) | Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition | |
| CN108096536A (en) | A kind of Chinese medicine composition for treating hemiplegia | |
| CN103961603B (en) | Traditional Chinese medicine preparationcapable of reducing blood fat and freeing vessels | |
| CN103656277B (en) | The medicine for the treatment of hepatic ascites | |
| CN103735879A (en) | Traditional Chinese medicine decoction for treating carotid artery plaque | |
| CN103638275B (en) | Chinese medicinal formulae of a kind of coronary flow that increases sharply and preparation method thereof | |
| CN101244209B (en) | Medicament for preventing or treating cardiovascular and cerebrovascular diseases | |
| CN101618187A (en) | Medicine for treating liver cancer and preparation method thereof | |
| CN106822852A (en) | Treat pharmaceutical composition, its preparation technology and the purposes of coronary heart disease | |
| CN106511829A (en) | Yao medicine tub-bath preparation capable of reducing blood pressure, blood sugar and blood fat, and preparation method thereof | |
| CN100346813C (en) | Medicine for treating coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160224 |